Form 4: Anixa Biosciences Director Lewis H. Titterton Jr. Acquires Additional Shares

Director Lewis H. Titterton Jr. of Anixa Biosciences Inc. [ANIX] purchased 405 shares of common stock on June 13, 2024, at a price of $2.7 per share.

Summary

• On June 13, 2024, Lewis H. Titterton Jr., a director of Anixa Biosciences Inc. [ANIX], acquired 405 shares of common stock.
• The purchase price was $2.7 per share.
• Following the transaction, Titterton directly owns 856,612 shares of Anixa Biosciences Inc.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing detailing a stock purchase by a company director. It doesn't inherently convey positive or negative sentiment.

Industry Context

This is a routine disclosure of insider trading activity. It is common for directors and officers of publicly traded companies to buy or sell shares of their company's stock. These transactions are closely monitored by regulators and investors as they can provide insights into management's view of the company's prospects.

Stakeholder Impact

• The purchase of shares by a director could be viewed positively by shareholders as it signals confidence in the company's future.

Key Dates